Breadcrumb Home investors investor resources Investor Resources Quick Explore Corporate Governance Shareholding Pattern Investor contact Year 2026-20272025-20262024-20252023-20242022-20232021-20222020-20212019-20202018-20192017-2018 Apply Schedule of Analyst and Institutional Investors meetings 26th Jun 2020 Schedule of Analyst and Institutional Investors meetings 23rd Jun 2020 Press Release - Cipla launches Cipremi (remdesivir lyophilised powder for injection 100 mg), the only U.S. FDA approved Emergency Use Authorisation (EUA) treatment for patients with severe COVID-19 disease 21st Jun 2020 Public Notice - Transfer of Equity Shares to IEPF – 2020 19th Jun 2020 Newspaper Publication of Notice to Shareholders whose shares are liable to be transferred to IEPF 19th Jun 2020 Press Release - Cipla expands partnership with Roche Pharma India to further improve access to key oncology medicines 18th Jun 2020 Schedule of Analyst and Institutional Investors meetings 17th Jun 2020 Record of Investor Meetings – June’20 15th Jun 2020 Acquisition of stake in Goapptiv Private Limited 10th Jun 2020 Large Corporate Disclosure – FY 2019-20 10th Jun 2020 + BSE and NSE Quotes by TradingView The displayed data is not in real time and may have streaming delays.
